Showing posts with label in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder. Show all posts
Showing posts with label in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder. Show all posts
Wednesday, June 13, 2018

FDA Approves Supplemental New Drug Application for Myrbetriq (mirabegron) for Use in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder Symptoms

›
In continuation of my update on  mirabegron Astellas Pharma Inc. announced  that the U.S. Food and Drug Administration (FDA) has app...